🔎 Trials Near Me

Home › Interstitial Lung Diseases

Interstitial Lung Diseases clinical trials recruiting in the U.S.

54 studies for Interstitial Lung Diseases are recruiting participants at sites across the United States.

Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.

Cities with the most studies

By state

Recently updated studies

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923

Pulmonary Fibrosis Foundation Community Registry

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05382572

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06806592

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07323732

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Recruiting
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07269262

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 11, 2026 · NCT07816185

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 8, 2026 · NCT07473700

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07285655

Dorothy P. and Richard P. Simmons Center for ILD Research Registry

RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT00258583

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07486869

Platform Clinical Study for Conquering Scleroderma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Aug 18, 2026 · NCT06855329

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

RecruitingPhase 2
Ages 8 to 60 · All sexes · Updated Aug 14, 2026 · NCT03630211

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.